2 research outputs found
MOESM1 of Metabolic syndrome is independently associated with increased 20-year mortality in patients with stable coronary artery disease
Additional file 1: Table S1. Differences between the MetS definitions in terms of their individual components
MOESM1 of The addition of vildagliptin to metformin prevents the elevation of interleukin 1ß in patients with type 2 diabetes and coronary artery disease: a prospective, randomized, open-label study
Additional file 1: Table S1. Showing the percentage change {Δ% = [(value after treatment - baseline value)/baseline value * 100]} in each group of patients after 12 weeks of treatment